| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/13/2002 | EP1179187A1 Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid |
| 02/13/2002 | EP1179186A2 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 02/13/2002 | EP1179185A1 A method of detecting an analyte using semiconductor nanocrystals |
| 02/13/2002 | EP1179184A1 Identifying material from a breast duct |
| 02/13/2002 | EP1179183A1 A method for identifying pre-neoplastic and/or neoplastic states in mammals |
| 02/13/2002 | EP1179182A2 Diagnosis and treatment of atherosclerosis and coronary heart disease |
| 02/13/2002 | EP1179181A1 Microscale diffusion immunoassay |
| 02/13/2002 | EP1179180A1 Method for the identification and/or the quantification of a target compound |
| 02/13/2002 | EP1179179A1 Use of an antibody to detect basophiles and/or mast cells |
| 02/13/2002 | EP1179178A1 Improved method of identifying and locating immunobiologically-active linear peptides |
| 02/13/2002 | EP1179177A1 Polysaccharide structure and sequence determination |
| 02/13/2002 | EP1179176A1 Enriched antigen-specific t-cells, and related therapeutic and prophylactic compositions and methods |
| 02/13/2002 | EP1179175A2 Materials and methods relating to disease diagnosis |
| 02/13/2002 | EP1179174A2 Device and method for monitoring and controlling biologically active fluids |
| 02/13/2002 | EP1179094A2 Assay for the detection of paclitaxel resistant cells in human tumors |
| 02/13/2002 | EP1179093A1 Expression of ets-domain proteins in cancer |
| 02/13/2002 | EP1179092A2 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus |
| 02/13/2002 | EP1179091A1 Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method |
| 02/13/2002 | EP1179090A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 02/13/2002 | EP1179086A2 Methods of identifying therapeutic compounds in a genetically defined setting |
| 02/13/2002 | EP1179085A1 Method for sequencing nucleic acid molecules |
| 02/13/2002 | EP1179070A2 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
| 02/13/2002 | EP1179067A1 Neuroprotective properties of gdf-15, a novel member of the tgf-beta superfamily |
| 02/13/2002 | EP1179066A2 Extracellular signaling molecules |
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179063A2 Genes expressed in hippocampus |
| 02/13/2002 | EP1179061A1 Methods for treating tumors using antiangiogenic compounds |
| 02/13/2002 | EP1179059A1 Isolating biological modulators from biodiverse gene fragment libraries |
| 02/13/2002 | EP1179056A1 Mixed-bed solid phase and its use in the isolation of nucleic acids |
| 02/13/2002 | EP1179052A2 Serine proteases |
| 02/13/2002 | EP1179028A1 Solvent resistant photosensitive compositions |
| 02/13/2002 | EP1179022A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179021A1 Human gaba b receptor 1 promoters |
| 02/13/2002 | EP1179018A1 Interaction between the vhl tumour suppressor and hypoxia inducible factor, and assay methods relating thereto |
| 02/13/2002 | EP1179015A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
| 02/13/2002 | EP1179010A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179007A1 Self-assembling biomolecular structures |
| 02/13/2002 | EP1179002A1 Methods using mechanisms of action of aroa |
| 02/13/2002 | EP1178999A2 L-ribo-lna analogues |
| 02/13/2002 | EP1178954A1 A structure-based approach to design inhibitors of protein-processivity factor interactions |
| 02/13/2002 | EP1178835A1 Compositions and methods for improving learning and memory |
| 02/13/2002 | EP1178830A2 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 02/13/2002 | EP1178829A1 Human monoclonal antibody |
| 02/13/2002 | EP1178828A1 Death domain containing receptor 4 |
| 02/13/2002 | EP1178824A2 Staphylococcus aureus antigen-containing whole cell vaccine |
| 02/13/2002 | EP1178821A1 Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 02/13/2002 | EP1178814A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders |
| 02/13/2002 | EP1178803A2 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 02/13/2002 | EP1178722A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING |
| 02/13/2002 | EP1088285A4 Method of unsupervised cell nuclei segmentation |
| 02/13/2002 | EP1057016A4 Machine readable assaying system using changeable indicia |
| 02/13/2002 | EP1019726B1 Prevention of sudden infant death |
| 02/13/2002 | EP1007671B1 Fanconi-gen ii |
| 02/13/2002 | EP0916089B1 Process and device for suppressing cross girder signals when inspecting prestressed concrete construction elements by the residual magnetic field measurement method |
| 02/13/2002 | EP0904403B1 Protein kinase assay as a method for identification of fungicides |
| 02/13/2002 | EP0876503B1 Process for assessing the activity of drugs |
| 02/13/2002 | EP0868656B1 Method and device for measuring electromagnetic waves emanating from a melt |
| 02/13/2002 | EP0866878A4 Detection of mammary tumor virus-like sequences in human breast cancer |
| 02/13/2002 | EP0862729B1 Composite structure resin cure monitoring using an optical fiber grating sensor |
| 02/13/2002 | EP0859793B1 Conjugation of ligand to immobilized protein in organic solvent |
| 02/13/2002 | EP0812859B1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME |
| 02/13/2002 | EP0804737B1 Method for screening the risk of gastric cancer |
| 02/13/2002 | EP0788603B1 Separation of magnetic microparticles involving a pre-concentration step |
| 02/13/2002 | EP0787297B1 Two-stage separation method |
| 02/13/2002 | EP0690927A4 Fluorescent detection of nonviable cells |
| 02/13/2002 | EP0663015B1 Detection of motile cells in a sample |
| 02/13/2002 | CN1335936A Coupling of lipopolysaccharide-derived carbohydrates onto solid surfaces |
| 02/13/2002 | CN1335893A Statistical combining of cell expression profiles |
| 02/13/2002 | CN1335892A Phytomics: A genomic-based approach to herbal compositions |
| 02/13/2002 | CN1335887A Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 02/13/2002 | CN1335789A Apparatus and methods for efficient processing of biological samples on slides |
| 02/13/2002 | CN1335727A Method and apparatus for recording caption |
| 02/13/2002 | CN1335506A 反向蛋白质芯片 Reverse protein chips |
| 02/13/2002 | CN1335505A Protein chip based on labeling streptavidin-biotin technology |
| 02/13/2002 | CN1335504A Protein chip for immunological analysis |
| 02/13/2002 | CN1335503A Double-mark fast diagnosis reagent kit with immuno-colloid gold and immuno-magnetic particle |
| 02/13/2002 | CN1335502A Fast gold mark test reagent kit for one-step multiple-index test of myocardial infarction |
| 02/13/2002 | CN1335501A Multiple-sample microarray biochip |
| 02/13/2002 | CN1335500A Urine sedimentation detecting method |
| 02/12/2002 | US6347284 System for prediction of adhesion energy at interface between dissimilar materials and method thereof |
| 02/12/2002 | US6346819 Method and device for determining proportions of solid matter in a test material |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346608 MecB |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346606 A protein; diagnosis and therapy for tumor diseases, central nervous system diseases, glioblastomas, and breast cancer |
| 02/12/2002 | US6346548 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 02/12/2002 | US6346422 Method of selecting bacterial strains |
| 02/12/2002 | US6346421 Adding sample to ultracentrifuge tube having distinct regions which taper to bottom of tube where inner lining is serrated, then centrifuging; for fast classification |
| 02/12/2002 | US6346420 Activating resistive heating element to burn gas mixture, measuring electrical signal at terminals during combustion, then comparing values of signal measured during transient phase when concentration of gas is decreasing |
| 02/12/2002 | US6346419 Efficient and accurate single-channel system that measures nitrogen dioxide using ultraviolet light source; higher conversion efficiency at faster time response; lower power consumption; less heat output with less sample heating |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346406 Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor |
| 02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
| 02/12/2002 | US6346391 Treating infection by administering drug to which the microorganism is resistant and an inhibitor of an acrab-like efflux pump |
| 02/12/2002 | US6346390 Receptor derived peptides involved in modulation of response to ligand binding |
| 02/12/2002 | US6346389 Controlling cell apoptosis |
| 02/12/2002 | US6346388 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 02/12/2002 | US6346387 Detection of binding reactions using labels detected by mediated catalytic electrochemistry |
| 02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |